BMO Capital Maintains Market Perform on Medpace Holdings, Lowers Price Target to $400

Benzinga Newsdesk www.benzinga.com Negative 74.4%

Neg 74.4% Neu 0% Pos 0%

BMO Capital analyst Sean Dodge maintains Medpace Holdings (NASDAQ:MEDP) with a Market Perform and lowers the price target from $460 to $400.